Literature DB >> 11813899

Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.

M Barbara1, C Consagra, S Monini, G Nostro, A Harguindey, A Vestri, R Filipo.   

Abstract

Treatment of Ménière's disease (MD) is still controversial and pressure changes transmitted to the inner ear have been reported to have effects similar to those of other non-surgical therapies. This paper reports on a clinical trial of MD patients which has been carried out using a portable piece of equipment, called Meniett, which delivers a pulsed, controlled, positive pressure to the middle ear, provided that a ventilation tube (VT) has previously been inserted. A comparison was made of the number of vertigo spells during the 2 months before treatment and during the 40-day treatment period. In addition, within this latter period a comparison was made between use of VT and use of VT + Meniett. Use of VT only had a positive effect in 90% of patients, with either absence (n = 10: 50%) or marked reduction (n = 8; 40%) in episodes of vertigo. When Meniett was also applied, stabilization of the positive effect on vertigo was registered, with a concomitant improvement in hearing threshold in 2 patients (10%). Although a longer and more reliable long-term follow-up of this treatment is needed, it is possible to propose the use of this therapeutic approach as it has been proven to induce a dramatic improvement in the symptoms affecting patients with Ménière's disease during reactivation of the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11813899

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

Review 1.  [Surgical treatment of vestibular vertigo: methods and indications].

Authors:  M Westhofen
Journal:  HNO       Date:  2008-10       Impact factor: 1.284

2.  The Clinical Benefit of Device Therapy for Meniere's Disease in Adults: Systematic Review and Meta-Analysis.

Authors:  Shu Jia Wang; Hong Yang; Yang-Yang Yao; Hui-Yun Gu; Lu-Lu Lin; Chao Zhang; Jie Luo
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.